Sources of Medical Technology: Universities and Industry (1995)
Chapter: APPENDIX A: WORKSHOP AGENDA
Appendix A
Workshop Agenda
THE UNIVERSITY-INDUSTRY INTERFACE AND MEDICAL INNOVATION
Sunday, February 21, 1993
2:30 p.m. | Welcome Kenneth Shine, President, Institute of Medicine; Introduction to the Workshop Enriqueta Bond, Executive Officer, Institute of Medicine |
Session I. Setting The Stage | |
Moderator: | Ken Melmon, Stanford University Some Further Thoughts on the Origin of the Workshop |
3:00 | Medical Innovation and the Economic Environment Victor Fuchs, Stanford University |
3:30 | R&D Management: An Academic Perspective Stanley Cohen, Stanford University |
4:00 | Institutional Factors Affecting the University-Industry Interface Niels Reimers, Technology Linkages International |
4:30 | Discussion |
5:00 | R&D Management: An Industrial Perspective Alejandro Zaffaroni, ALZA Corporation |
5:30 | The Evolution of Biotechnology Drugs at AMGEN and ICOS George Rathmann, ICOS |
Respondent: | Joel Birnbaum, Hewlett-Packard |
6:00 | Discussion |
7:00 | Adjourn and Dinner |
Monday, February 22, 1993
8:15 a.m. | Continental Breakfast |
Session II. Medical Device Innovation | |
Moderator: | Bill Hubbard, Former President, The Upjohn Company |
Respondents: | Ben Holmes, Hewlett-Packard; James Benson, Health Industry Manufacturers Association; and Harvey Rudolph, Food and Drug Administration |
8:45 | Minimally Invasive Therapy: The Case of Endoscopy Introduction: Nathan Rosenberg, Stanford University, and Annetine Gelijns, Institute of Medicine/Columbia University Discussion |
9:45 | The Laser in Medicine: Birth of a New Industry Introduction: Joanne Spetz, Stanford University Discussion |
10:45 | Break |
11:00 | Cardiovascular Diagnostics Introduction: Stan Finkelstein, Massachusetts Institute of Technology, Gregory Bell, Charles River Associates, and Kevin Neels, Quintiles Discussion |
12:00 | Medical Imaging: MRI and PET Introduction: Richard Rettig, Institute of Medicine, Holly Dawkins, Institute of Medicine, and Everette James, Vanderbilt University Discussion |
1:00 | Lunch |
2:15 | Cochlear Implants Introduction: Stuart Blume, University of Amsterdam Discussion |
Session III. Pharmaceutical And Biotech Innovation | |
Moderator: | Stanley Reiser, University of Texas Health Science Center |
Respondents: | Gerald Laubach, Former President, Pfizer; Rebecca Henderson, Massachusetts Institute of Technology; James Benson, Health Industry Manufacturers Association |
3:15 | Purine Metabolism and the Development of Chemotherapeutic Agents Introduction: Chris Flowers and Ken Melmon, Stanford University Discussion |
4:15 | Break |
4:30 | Innovation in Biotechnology: The Case of the Small Firm Introduction: Alfonso Gambardella, Bocconi University, Milan, and Ashish Arora, Carnegie-Mellon University Discussion |
5:30 | Adjournment |
Tuesday, February 23, 1993
Session III. Pharmaceutical And Biotech Innovation (continued) | |
Moderator: | Stanley Reiser, University of Texas Health Science Center |
Respondents: | Gerald Laubach, Former President, Pfizer; Rebecca Henderson, Massachusetts Institute of Technology; James Benson, Health Industry Manufacturers Association |
8:00 a.m. | Innovation in Compounds to Treat Diabetes Introduction: Scott Stern, Stanford University Discussion |
9:00 | What Is Public? What Is Private? And What Should Be? Richard Nelson, Columbia University Discussion |
9:30 | General Discussion |
10:00 | Break |
10:30 | Where Do We Go From Here? Ken Melmon, Stanford University Richard Nelson, Columbia University Nathan Rosenberg, Stanford University |
11:00 | Adjournment |
